Cilostazol 100 mg Tablet Formulations Under Fasting Conditions
Status:
Completed
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
The objective of this randomized, single-dose, two-way evaluation is to compare the
bioequivalence of a test cilostazol formulation to an equivalent oral dose of the
commercially available cilostazol in a test population of 36 adult subjects under fasting
conditions.